Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients.
Chen Y, Li Y, Qi C, Zhang C, Liu D, Deng Y, Fu Y, Khadka VS, Wang DD, Tan S, Liu S, Peng Z, Gong J, Lin PP, Zhang X, Li J, Li Y, Shen L.
Chen Y, et al. Among authors: zhang c, zhang x.
Cancer Lett. 2021 Oct 1;517:78-87. doi: 10.1016/j.canlet.2021.06.002. Epub 2021 Jun 11.
Cancer Lett. 2021.
PMID: 34126192
Free article.